A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

Novo Nordisk Investigational Site

Tucson, Arizona, United States, 85724

Novo Nordisk Investigational Site

Los Angeles, California, United States, 90022

Novo Nordisk Investigational Site

San Dimas, California, United States, 91773

Novo Nordisk Investigational Site

Aurora, Colorado, United States, 80045

Novo Nordisk Investigational Site

Orlando, Florida, United States, 32804

Novo Nordisk Investigational Site

Kansas City, Missouri, United States, 64111

Novo Nordisk Investigational Site

Houston, Texas, United States, 77054

Novo Nordisk Investigational Site

San Antonio, Texas, United States, 78215

Novo Nordisk Investigational Site

San Antonio, Texas, United States, 78233

Novo Nordisk Investigational Site

Seattle, Washington, United States, 98195

Novo Nordisk Investigational Site

Spokane, Washington, United States, 99204

Novo Nordisk Investigational Site

Toronto, Ontario, Canada, M5G 2N2

Novo Nordisk Investigational Site

Copenhagen, Denmark, 2100

Novo Nordisk Investigational Site

Herlev, Denmark, 2730

Novo Nordisk Investigational Site

AMIENS cedex 1, France, 80054

Novo Nordisk Investigational Site

Bois-Guillaume, France, 76230

Novo Nordisk Investigational Site

Grenoble – Cédex 09, France, 38043

Novo Nordisk Investigational Site

Reims, France, 51092

Novo Nordisk Investigational Site

Toulouse, France, 31059

Novo Nordisk Investigational Site

Milano, MI, Italy, 20132

Novo Nordisk Investigational Site

Bergamo, Italy, 24127

Novo Nordisk Investigational Site

Padova, Italy, 35128

Novo Nordisk Investigational Site

Roma, Italy, 00189

Novo Nordisk Investigational Site

Bydgoszcz, Poland, 85-048

Novo Nordisk Investigational Site

Radom, Poland, 26-600

Novo Nordisk Investigational Site

Szczecin, Poland, 70-111

Novo Nordisk Investigational Site

Warszawa, Poland, 04-749

Novo Nordisk Investigational Site

Zabrze, Poland, 41-800

Novo Nordisk Investigational Site

Durban, KwaZulu-Natal, South Africa, 4001

Novo Nordisk Investigational Site

Durban, KwaZulu-Natal, South Africa, 4092

Novo Nordisk Investigational Site

Cape Town, Western Cape, South Africa, 7925

Novo Nordisk Investigational Site

Barcelona, Spain, 08035

Novo Nordisk Investigational Site

Hospitalet de Llobregat, Spain, 08907

Novo Nordisk Investigational Site

Valencia, Spain, 46010

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 15, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments